| NF‐κB and epithelial to mesenchymal transition of cancer C Min, SF Eddy, DH Sherr, GE Sonenshein Journal of cellular biochemistry 104 (3), 733-744, 2008 | 466 | 2008 |
| An atlas of healthy and injured cell states and niches in the human kidney BB Lake, R Menon, S Winfree, Q Hu, R Melo Ferreira, K Kalhor, ... Nature 619 (7970), 585-594, 2023 | 377 | 2023 |
| An eQTL landscape of kidney tissue in human nephrotic syndrome CE Gillies, R Putler, R Menon, E Otto, K Yasutake, V Nair, P Hoover, ... The American Journal of Human Genetics 103 (2), 232-244, 2018 | 183 | 2018 |
| Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury CE Pedigo, GM Ducasa, F Leclercq, A Sloan, A Mitrofanova, T Hashmi, ... The Journal of clinical investigation 126 (9), 3336-3350, 2016 | 177 | 2016 |
| Inducible IκB kinase/IκB kinase ε expression is induced by CK2 and promotes aberrant nuclear factor-κB activation in breast cancer cells SF Eddy, S Guo, EG Demicco, R Romieu-Mourez, E Landesman-Bollag, ... Cancer research 65 (24), 11375-11383, 2005 | 167 | 2005 |
| Integrated multi-omics approaches to improve classification of chronic kidney disease S Eddy, LH Mariani, M Kretzler Nature Reviews Nephrology 16 (11), 657-668, 2020 | 151 | 2020 |
| Metabolic pathways and immunometabolism in rare kidney diseases PC Grayson, S Eddy, JN Taroni, YL Lightfoot, L Mariani, H Parikh, ... Annals of the rheumatic diseases 77 (8), 1226-1233, 2018 | 146 | 2018 |
| Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker R Menon, EA Otto, P Hoover, S Eddy, L Mariani, B Godfrey, CC Berthier, ... JCI insight 5 (6), e133267, 2020 | 140 | 2020 |
| MultiPLIER: a transfer learning framework for transcriptomics reveals systemic features of rare disease JN Taroni, PC Grayson, Q Hu, S Eddy, M Kretzler, PA Merkel, CS Greene Cell systems 8 (5), 380-394. e4, 2019 | 130 | 2019 |
| RelB NF-κB represses estrogen receptor α expression via induction of the zinc finger protein Blimp1 X Wang, K Belguise, CF O'Neill, N Sánchez-Morgan, M Romagnoli, ... Molecular and cellular biology 29 (14), 3832-3844, 2009 | 96 | 2009 |
| Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate SF Eddy, SE Kane, GE Sonenshein Cancer Research 67 (19), 9018-9023, 2007 | 95 | 2007 |
| Differential expression of Akt, PPARγ, and PGC-1 during hibernation in bats SF Eddy, KB Storey Biochemistry and cell biology 81 (4), 269-274, 2003 | 86 | 2003 |
| Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis A Mitrofanova, J Molina, JV Santos, J Guzman, XA Morales, GM Ducasa, ... Kidney international 94 (6), 1151-1159, 2018 | 84 | 2018 |
| SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease R Menon, EA Otto, R Sealfon, V Nair, AK Wong, CL Theesfeld, X Chen, ... Kidney international 98 (6), 1502-1518, 2020 | 83 | 2020 |
| Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy L Wu, C Liu, DY Chang, R Zhan, J Sun, SH Cui, S Eddy, V Nair, E Tanner, ... Kidney international 100 (1), 107-121, 2021 | 81 | 2021 |
| JAK-STAT signaling is activated in the kidney and peripheral blood cells of patients with focal segmental glomerulosclerosis J Tao, L Mariani, S Eddy, H Maecker, N Kambham, K Mehta, J Hartman, ... Kidney international 94 (4), 795-808, 2018 | 81 | 2018 |
| Organoid single cell profiling identifies a transcriptional signature of glomerular disease JL Harder, R Menon, EA Otto, J Zhou, S Eddy, NL Wys, C O’Connor, J Luo, ... JCI insight 4 (1), e122697, 2019 | 79 | 2019 |
| Construction of a computable cell proliferation network focused on non-diseased lung cells JW Westra, WK Schlage, BP Frushour, S Gebel, NL Catlett, W Han, ... BMC systems biology 5, 1-16, 2011 | 75 | 2011 |
| Cloning and expression of PPARγ and PGC-1α from the hibernating ground squirrel, Spermophilus tridecemlineatus SF Eddy, P Morin, KB Storey Molecular and cellular biochemistry 269, 175-182, 2005 | 73 | 2005 |
| SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes JA Schaub, FM AlAkwaa, PJ McCown, AS Naik, V Nair, S Eddy, R Menon, ... The Journal of clinical investigation 133 (5), 2023 | 67 | 2023 |
Matthias KretzlerProfessor of Internal Medicine, University of MichiganEmail được xác minh tại umich.edu
